^
    BIOMARKER:
    TMB-H
    i
    Other names: TMB | Tumor Mutational Burden
    Related biomarkers:
    Expression
    Mutation
    Others
    TMB-H
    Neuroendocrine Tumor
    pembrolizumab
    Sensitive
    :
    A2
    NCCN - 3wk
    TMB-H
    Solid Tumor
    pembrolizumab
    Sensitive
    :
    A1
    TMB-H
    Peritoneal Cancer
    pembrolizumab
    Sensitive
    :
    A2
    TMB-H
    Gastric Cancer
    pembrolizumab
    Sensitive
    :
    A2
    TMB-H
    Testicular Seminoma
    TIP
    Sensitive
    :
    A2
    TMB-H
    Sarcoma
    pembrolizumab
    Sensitive
    :
    A2
    TMB-H
    Thyroid Gland Hurthle Cell Carcinoma
    pembrolizumab
    Sensitive
    :
    A2
    TMB-H
    Chordoma
    pembrolizumab
    Sensitive
    :
    A2
    TMB-H
    Germ Cell Tumors
    pembrolizumab
    Sensitive
    :
    A2
    TMB-H
    Thyroid Gland Follicular Carcinoma
    pembrolizumab
    Sensitive
    :
    A2
    TMB-H
    Thyroid Gland Medullary Carcinoma
    pembrolizumab
    Sensitive
    :
    A2
    TMB-H
    Endometrial Cancer
    pembrolizumab
    Sensitive
    :
    A2
    TMB-H
    Cervical Cancer
    pembrolizumab
    Sensitive
    :
    A2
    TMB-H
    Thyroid Gland Papillary Carcinoma
    pembrolizumab
    Sensitive
    :
    A2
    TMB-H
    NSCLC
    nivolumab + ipilimumab
    Sensitive
    :
    A2
    TMB-H
    Breast Cancer
    pembrolizumab
    Sensitive
    :
    A2
    TMB-H
    Melanoma
    nivolumab + ipilimumab
    Sensitive
    :
    A2
    TMB-H
    Ewing Sarcoma
    pembrolizumab
    Sensitive
    :
    A2
    TMB-H
    Osteosarcoma
    pembrolizumab
    Sensitive
    :
    A2
    TMB-H
    Thyroid Gland Anaplastic Carcinoma
    pembrolizumab
    Sensitive
    :
    A2
    TMB-H
    Gastroesophageal Junction Adenocarcinoma
    pembrolizumab
    Sensitive
    :
    A2
    TMB-H
    Esophageal Cancer
    pembrolizumab
    Sensitive
    :
    A2
    TMB-H
    Ovarian Cancer
    pembrolizumab
    Sensitive
    :
    A2
    TMB-H
    Fallopian Tube Cancer
    pembrolizumab
    Sensitive
    :
    A2
    TMB-H
    NSCLC
    atezolizumab
    Sensitive
    :
    B
    VERI is free for non-commercial use, no login needed.
    Content on this site is for research purposes only and is not intended  to be a substitute for medical advice.
    For commercial access, including additional premium features, please contact us.
    By using VERI, you are agreeing to our
    and
    Privacy Policy
    ACCEPT COOKIES